March 19, 2019 / 11:30 AM / 6 months ago

BUZZ-Aurora Cannabis: Gains on procurement deal with Australia's Cann

** U.S.-listed shares of Aurora Cannabis up 3 pct at $10.24 in premarket trading; stock among the top traded shares across U.S. exchanges before the bell

** ACB ties bit.ly/2Y8pgar up with Australian medicinal cannabis cultivator Cann Group Ltd to buy medical cannabis produced at CAN’s facilities until 2024

** ACB will buy all production beyond what is needed by patients of CAN, whose shares closed 37.7 pct higher on Tuesday on the ASX

** The deal, whose specific terms and pricing were not disclosed by CAN, also features a price review mechanism

** CAN says ACB, which named billionaire investor Nelson Peltz as a strategic advisor last week, holds a 22.9 pct stake in the Australian firm

** Up to Monday’s close, Aurora’s U.S.-listed stock has doubled this year, compared with a 53.7 pct jump in the ETFMG Alternative Harvest ETF (Reporting by Aaron Saldanha in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below